Graft versus host disease in a liver transplant patient with hepatitis B and hepatocellular carcinoma.
Merhav
H J
HJ
Department of Surgery B, Tel Aviv Medical Center, Tel Aviv University, Sackler School of Medicine, Petach Tikvah, Israel.
Landau
M
M
Gat
A
A
Gazit
E
E
Baratz
M
M
Bialy-Golan
A
A
Konikof
F
F
Bril
S
S
Nakache
R
R
D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000601:surgery*; D003520:Cyclophosphamide / Q000627:therapeutic use; D017809:Fatal Outcome; D005938:Glucocorticoids / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000628:therapy*; D006509:Hepatitis B / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000150:complications* / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone